Marion K. Mateos

1.2k total citations
20 papers, 499 citations indexed

About

Marion K. Mateos is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Marion K. Mateos has authored 20 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 12 papers in Public Health, Environmental and Occupational Health and 4 papers in Hematology. Recurrent topics in Marion K. Mateos's work include Acute Lymphoblastic Leukemia research (11 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Acute Myeloid Leukemia Research (3 papers). Marion K. Mateos is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Acute Myeloid Leukemia Research (3 papers). Marion K. Mateos collaborates with scholars based in Australia, Netherlands and United States. Marion K. Mateos's co-authors include Glenn M. Marshall, Belamy B. Cheung, William A. Weiss, Daniel R. Carter, Justin Meyerowitz, Tao Liu, Toby N. Trahair, Draga Barbaric, Claire E. Wakefield and Janine Vetsch and has published in prestigious journals such as Nature reviews. Cancer, Blood and British Journal of Cancer.

In The Last Decade

Marion K. Mateos

17 papers receiving 494 citations

Peers

Marion K. Mateos
Paul Brons Netherlands
Beverly Bell United States
Karen Burns United States
Leslie Robison United States
Dana Barnea United States
Smita Dandekar United States
F. Breatnach Ireland
Marion K. Mateos
Citations per year, relative to Marion K. Mateos Marion K. Mateos (= 1×) peers Francesco Felicetti

Countries citing papers authored by Marion K. Mateos

Since Specialization
Citations

This map shows the geographic impact of Marion K. Mateos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion K. Mateos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion K. Mateos more than expected).

Fields of papers citing papers by Marion K. Mateos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion K. Mateos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion K. Mateos. The network helps show where Marion K. Mateos may publish in the future.

Co-authorship network of co-authors of Marion K. Mateos

This figure shows the co-authorship network connecting the top 25 collaborators of Marion K. Mateos. A scholar is included among the top collaborators of Marion K. Mateos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion K. Mateos. Marion K. Mateos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Catriona, Toby N. Trahair, Rishi S. Kotecha, et al.. (2025). Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond Treatment. Cancers. 17(7). 1238–1238.
2.
Hetherington, Kate, et al.. (2024). Second Opinion Seeking in Paediatric Oncology: Motivations and Predictors. Psycho-Oncology. 33(11). e70011–e70011. 1 indexed citations
3.
Manoharan, Neevika, Marion K. Mateos, Tim Hassall, et al.. (2024). Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement. The Medical Journal of Australia. 220(10). 533–538.
5.
Kotecha, Rishi S., et al.. (2024). Down syndrome-associated leukaemias: current evidence and challenges. Therapeutic Advances in Hematology. 15. 1574175661–1574175661. 5 indexed citations
6.
Thomsen, Birthe Lykke, Bodil Als‐Nielsen, Rachel Conyers, et al.. (2023). Physician-defined severe toxicities occurring during and after cancer treatment: Modified consensus definitions and clinical applicability in the evaluation of cancer treatment. Frontiers in Pediatrics. 11. 1155449–1155449.
7.
Wakefield, Claire E., Kate Hetherington, Eden G. Robertson, et al.. (2023). Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives. British Journal of Cancer. 129(10). 1634–1644. 10 indexed citations
8.
Celermajer, David S., André La Gerche, John D. O’Sullivan, et al.. (2023). Lessons learnt in the first year of an Australian pediatric cardio oncology clinic. Cardio-Oncology. 9(1). 45–45. 2 indexed citations
9.
Fardell, Joanna E., Mark W. Donoghoe, Rishi S. Kotecha, et al.. (2022). Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia. BMC Cancer. 22(1). 985–985. 8 indexed citations
10.
Mateos, Marion K., Anna Basu, Michael Wright, et al.. (2022). Developmental delay and progressive seizures in 2‐month‐old child with diffuse MRI abnormalities. Brain Pathology. 32(4). e13049–e13049. 1 indexed citations
11.
Mateos, Marion K., Glenn M. Marshall, Pasquale Barbaro, et al.. (2021). Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia. Haematologica. 107(3). 635–643. 29 indexed citations
12.
Signorelli, Christina, Claire E. Wakefield, Jordana K. McLoone, et al.. (2020). A cost‐effective approach to increasing participation in patient‐reported outcomes research in cancer: A randomized trial of video invitations. International Journal of Cancer. 148(4). 971–980. 8 indexed citations
13.
Mateos, Marion K., Toby N. Trahair, Chelsea Mayoh, et al.. (2019). Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia. Thrombosis Research. 178. 132–138. 13 indexed citations
14.
Vetsch, Janine, Claire E. Wakefield, Eden G. Robertson, et al.. (2018). Health-related quality of life of survivors of childhood acute lymphoblastic leukemia: a systematic review. Quality of Life Research. 27(6). 1431–1443. 62 indexed citations
15.
Fardell, Joanna E., Janine Vetsch, Toby N. Trahair, et al.. (2017). Health‐related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review. Pediatric Blood & Cancer. 64(9). 66 indexed citations
16.
Mateos, Marion K., Toby N. Trahair, Chelsea Mayoh, et al.. (2016). Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia. Blood. 128(22). 1182–1182. 2 indexed citations
17.
Barbaro, Pasquale, Marion K. Mateos, Luciano Dalla‐Pozza, et al.. (2015). Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity. Blood. 126(23). 4984–4984. 1 indexed citations
18.
Mateos, Marion K., et al.. (2015). Down syndrome and leukemia: insights into leukemogenesis and translational targets.. PubMed. 4(2). 76–92. 54 indexed citations
19.
Marshall, Glenn M., Daniel R. Carter, Belamy B. Cheung, et al.. (2014). The prenatal origins of cancer. Nature reviews. Cancer. 14(4). 277–289. 184 indexed citations
20.
Mateos, Marion K., Tracey O’Brien, Melissa Gabriel, et al.. (2013). Transplant‐related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25‐year retrospective review. Pediatric Blood & Cancer. 60(9). 1520–1527. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026